March 26, 2020
Due to concerns surrounding COVID-19, we are taking every precaution to protect our research participants, study partners, and staff. We have shut down our in-house research operations, including clinical trials. Our staff are working remotely from their homes and participants and study partners are not coming in for visits. For some studies, we are continuing to perform remote visits that consist of either phone calls with our staff or computerized tests that can be done from home. Our dedication to finding more effective treatments and a cure for Alzheimer’s disease continues as always, however we must focus on the medical crisis at hand and follow all recommended guidelines to keep people safe.
We do not know yet when we will resume normal operations. We are evaluating the situation on a weekly basis and are available via phone and email in the meantime.
Partners Healthcare has set up a COVID-19 hotline for clinicians, patients and the public at 617-724-7000. For the most accurate updates on COVID-19, visit: CDC.gov and/or WHO.int